Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 69

1.

Dengue Virus (DENV) Neutralizing Antibody Kinetics in Children After Symptomatic Primary and Postprimary DENV Infection.

Clapham HE, Rodriguez-Barraquer I, Azman AS, Althouse BM, Salje H, Gibbons RV, Rothman AL, Jarman RG, Nisalak A, Thaisomboonsuk B, Kalayanarooj S, Nimmannitya S, Vaughn DW, Green S, Yoon IK, Cummings DA.

J Infect Dis. 2016 May 1;213(9):1428-35. doi: 10.1093/infdis/jiv759. Epub 2015 Dec 23.

2.

Revealing the microscale spatial signature of dengue transmission and immunity in an urban population.

Salje H, Lessler J, Endy TP, Curriero FC, Gibbons RV, Nisalak A, Nimmannitya S, Kalayanarooj S, Jarman RG, Thomas SJ, Burke DS, Cummings DA.

Proc Natl Acad Sci U S A. 2012 Jun 12;109(24):9535-8. doi: 10.1073/pnas.1120621109. Epub 2012 May 29.

3.

Viscerotropic disease: case definition and guidelines for collection, analysis, and presentation of immunization safety data.

Gershman MD, Staples JE, Bentsi-Enchill AD, Breugelmans JG, Brito GS, Camacho LA, Cottin P, Domingo C, Durbin A, Gascon J, Guenaneche F, Hayes EB, Jelenik Z, Khromava A, Martins Rde M, Wilson MM, Massy N, Nasidi A, Niedrig M, Sherwat A, Tsai T, Vilella A, Wilson ME, Kohl KS; Brighton Collaboration Viscerotropic Disease Working Group.

Vaccine. 2012 Jul 13;30(33):5038-58. doi: 10.1016/j.vaccine.2012.04.067. Epub 2012 May 4. No abstract available.

4.

Preparing for introduction of a dengue vaccine: recommendations from the 1st Dengue v2V Asia-Pacific Meeting.

Lam SK, Burke D, Capeding MR, Chong CK, Coudeville L, Farrar J, Gubler D, Hadinegoro SR, Hanna J, Lang J, Lee HL, Leo YS, Luong CQ, Mahoney R, McBride J, Mendez-Galvan J, Ng LC, Nimmannitya S, Ooi EE, Shepard D, Smit J, Teyssou R, Thomas L, Torresi J, Vasconcelos P, Wirawan DN, Yoksan S.

Vaccine. 2011 Nov 28;29(51):9417-22. doi: 10.1016/j.vaccine.2011.08.047. Epub 2011 Aug 22.

5.

Dengue--how best to classify it.

Srikiatkhachorn A, Rothman AL, Gibbons RV, Sittisombut N, Malasit P, Ennis FA, Nimmannitya S, Kalayanarooj S.

Clin Infect Dis. 2011 Sep;53(6):563-7. doi: 10.1093/cid/cir451. Epub 2011 Aug 10.

6.

Classification of dengue illness based on readily available laboratory data.

Potts JA, Thomas SJ, Srikiatkhachorn A, Supradish PO, Li W, Nisalak A, Nimmannitya S, Endy TP, Libraty DH, Gibbons RV, Green S, Rothman AL, Kalayanarooj S.

Am J Trop Med Hyg. 2010 Oct;83(4):781-8. doi: 10.4269/ajtmh.2010.10-0135.

7.

Guillain-Barré syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data.

Sejvar JJ, Kohl KS, Gidudu J, Amato A, Bakshi N, Baxter R, Burwen DR, Cornblath DR, Cleerbout J, Edwards KM, Heininger U, Hughes R, Khuri-Bulos N, Korinthenberg R, Law BJ, Munro U, Maltezou HC, Nell P, Oleske J, Sparks R, Velentgas P, Vermeer P, Wiznitzer M; Brighton Collaboration GBS Working Group.

Vaccine. 2011 Jan 10;29(3):599-612. doi: 10.1016/j.vaccine.2010.06.003. Epub 2010 Jun 18. Review. No abstract available.

PMID:
20600491
8.

Molecular genetic relationship of the 3' untranslated region among Thai dengue-3 virus, Bangkok isolates, during 1973-2000.

Pankhong P, Weiner DB, Ramanathan MP, Nisalak A, Kalayanarooj S, Nimmannitya S, Attatippaholkun W.

DNA Cell Biol. 2009 Oct;28(10):481-91. doi: 10.1089/dna.2008.0835.

PMID:
19563250
9.

Cross-protective immunity can account for the alternating epidemic pattern of dengue virus serotypes circulating in Bangkok.

Adams B, Holmes EC, Zhang C, Mammen MP Jr, Nimmannitya S, Kalayanarooj S, Boots M.

Proc Natl Acad Sci U S A. 2006 Sep 19;103(38):14234-9. Epub 2006 Sep 11.

10.

Comparative analysis reveals no consistent association between the secondary structure of the 3'-untranslated region of dengue viruses and disease syndrome.

Zhou Y, Mammen MP Jr, Klungthong C, Chinnawirotpisan P, Vaughn DW, Nimmannitya S, Kalayanarooj S, Holmes EC, Zhang C.

J Gen Virol. 2006 Sep;87(Pt 9):2595-603.

PMID:
16894198
11.

Structure and age of genetic diversity of dengue virus type 2 in Thailand.

Zhang C, Mammen MP Jr, Chinnawirotpisan P, Klungthong C, Rodpradit P, Nisalak A, Vaughn DW, Nimmannitya S, Kalayanarooj S, Holmes EC.

J Gen Virol. 2006 Apr;87(Pt 4):873-83.

PMID:
16528037
12.

Clade replacements in dengue virus serotypes 1 and 3 are associated with changing serotype prevalence.

Zhang C, Mammen MP Jr, Chinnawirotpisan P, Klungthong C, Rodpradit P, Monkongdee P, Nimmannitya S, Kalayanarooj S, Holmes EC.

J Virol. 2005 Dec;79(24):15123-30.

13.

Randomized, placebo-controlled trial of nonpegylated and pegylated forms of recombinant human alpha interferon 2a for suppression of dengue virus viremia in rhesus monkeys.

Ajariyakhajorn C, Mammen MP Jr, Endy TP, Gettayacamin M, Nisalak A, Nimmannitya S, Libraty DH.

Antimicrob Agents Chemother. 2005 Nov;49(11):4508-14.

14.

Temporal trends of dengue fever/dengue hemorrhagic fever in Bangkok, Thailand from 1981 to 2000: an age-period-cohort analysis.

Kongsomboon K, Singhasivanon P, Kaewkungwal J, Nimmannitya S, Mammen MP Jr, Nisalak A, Sawanpanyalert P.

Southeast Asian J Trop Med Public Health. 2004 Dec;35(4):913-7.

PMID:
15916090
15.

Is dengue severity related to nutritional status?

Kalayanarooj S, Nimmannitya S.

Southeast Asian J Trop Med Public Health. 2005 Mar;36(2):378-84.

PMID:
15916044
16.

Neonatal dengue infection: report of dengue fever in a 1-day-old infant.

Petdachai W, Sila'on J, Nimmannitya S, Nisalak A.

Southeast Asian J Trop Med Public Health. 2004 Jun;35(2):403-7.

PMID:
15691146
17.

Clinical presentations of dengue hemorrhagic fever in infants compared to children.

Kalayanarooj S, Nimmannitya S.

J Med Assoc Thai. 2003 Aug;86 Suppl 3:S673-80.

PMID:
14700166
18.

Serotype-specific dengue virus circulation and dengue disease in Bangkok, Thailand from 1973 to 1999.

Nisalak A, Endy TP, Nimmannitya S, Kalayanarooj S, Thisayakorn U, Scott RM, Burke DS, Hoke CH, Innis BL, Vaughn DW.

Am J Trop Med Hyg. 2003 Feb;68(2):191-202.

PMID:
12641411
19.

Dengue hemorrhagic fever in infants: research opportunities ignored.

Halstead SB, Lan NT, Myint TT, Shwe TN, Nisalak A, Kalyanarooj S, Nimmannitya S, Soegijanto S, Vaughn DW, Endy TP.

Emerg Infect Dis. 2002 Dec;8(12):1474-9. Review.

20.

Extinction and rapid emergence of strains of dengue 3 virus during an interepidemic period.

Wittke V, Robb TE, Thu HM, Nisalak A, Nimmannitya S, Kalayanrooj S, Vaughn DW, Endy TP, Holmes EC, Aaskov JG.

Virology. 2002 Sep 15;301(1):148-56.

Supplemental Content

Loading ...
Support Center